Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
|
|
AN2 Therapeutics, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/24/2022 |
4/A
| Adjuvant Global Health Technology Fund, L.P. (10% Owner) has filed a Form 4 on AN2 Therapeutics, Inc.|
Txns:
| Converted 1,651,636 shares
@ $0
Converted 312,415 shares
@ $0
Converted 392,433 shares
@ $0
Converted 74,230 shares
@ $0
Bought 166,666 shares
@ $15, valued at
$2.5M
Converted 1,651,636 convertible preferred
@ $0
Converted 312,415 convertible preferred
@ $0
Converted 392,433 convertible preferred
@ $0
Converted 74,230 convertible preferred
@ $0 |
|
|
|